J. García‐Pagán

发表

Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis

R. Schwabe, R. Bataller, V. Arroyo, 2012, Gut.

Metabolomics as a diagnostic tool for idiopathic non‐cirrhotic portal hypertension

M. Martínez-Chantar, J. Lozano, A. Berzigotti, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Liver sinusoidal endothelial dysfunction after LPS administration: a role for inducible-nitric oxide synthase.

J. Bosch, J. García‐Pagán, J. Abraldes, 2014, Journal of hepatology.

Mitochondria-targeted antioxidant mitoquinone deactivates human and rat HSC and reduces portal hypertension in cirrhotic rats

M. Murphy, R. Deulofeu, J. García‐Pagán, 2017 .

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis

D. Colomer, J. Bosch, Mercedes Fernandez, 2006, Hepatology.

Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.

J. Bosch, M. Graupera, J. García‐Pagán, 2007, Journal of hepatology.

Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD

J. Bosch, J. García‐Pagán, J. Abraldes, 2012, PloS one.

Effects of simvastatin administration on rodents with lipopolysaccharide‐induced liver microvascular dysfunction

J. Bosch, J. García‐Pagán, R. Miquel, 2013, Hepatology.

Simvastatin maintains function and viability of steatotic rat livers procured for transplantation.

J. Bosch, C. Peralta, J. García‐Pagán, 2013, Journal of hepatology.

Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis.

Rosa Gilabert, J. Bosch, P. Tandon, 2010, Journal of hepatology.

Nontumoral portal vein thrombosis in patients awaiting liver transplantation

C. Fondevila, J. Fuster, J. García-Valdecasas, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage.

J. Llach, M. Navasa, J. Panés, 1996, Gastrointestinal endoscopy.

Effects of propranolol on venous compliance in conscious rats with pre-hepatic portal hypertension.

J. García‐Pagán, J. Bosch, J. Abraldes, 2006, Journal of hepatology.

A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injury.

C. Fondevila, J. Bosch, L. Arola, 2014, Clinical science.

Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers

G. Garcı́a-Cardeña, J. Bosch, J. García‐Pagán, 2012, Hepatology.

The management of portal hypertension: rational basis, available treatments and future options.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2008, Journal of hepatology.

Prevalence , and Clinical Significance of Abnormal ematologic Indices in Compensated Cirrhosis

R. Groszmann, A. Burroughs, J. García‐Pagán, 2022 .

Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.

R. Borrás, A. Berzigotti, J. García‐Pagán, 2021, Journal of hepatology.

Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.

J. García‐Pagán, J. Bosch, S. Seijo, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Nitric Oxide and Portal Hypertension

J. Bosch, J. García‐Pagán, J. González-Abraldes, 2002, Metabolic Brain Disease.

Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy

A. Burroughs, F. Nevens, R. Jalan, 2013, Hepatology.

Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy

À. Rovira, J. Alonso, J. García‐Pagán, 2006, Hepatology.

Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.

J. García‐Pagán, J. Bosch, S. Seijo, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study

J. Bosch, J. Calleja, A. Berzigotti, 2017, Hepatology.

Increased CD11b neutrophil expression in Budd–Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera

J. García‐Pagán, J. Bosch, J. Abraldes, 2004, British journal of haematology.

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.

S. Chevret, D. Valla, P. Fenaux, 2008, Blood.

Extrahepatic Portal Vein Thrombosis

J. Bosch, J. García‐Pagán, M. Hernández‐Guerra, 2008, Seminars in liver disease.

A Specialized, Nurse-Run Titration Clinic: A Feasible Option for Optimizing β-Blockade in Non–Clinical Trial Patients

J. Bosch, P. Tandon, A. Berzigotti, 2010, The American Journal of Gastroenterology.

Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.

M. Ronot, V. Vilgrain, J. García‐Pagán, 2019, Journal of hepatology.

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

J. Rodés, J. Bosch, Mercedes Fernandez, 2004, Gastroenterology.

Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial.

A. de Gottardi, J. Bosch, A. Berzigotti, 2012, The American journal of clinical nutrition.

Reply: To PMID 23058320.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2013, Gastroenterology.

Idiopathic Portal Hypertension

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2018, Hepatology.

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

X. Forns, J. Calleja, J. García‐Pagán, 2020, Journal of hepatology.

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

X. Forns, J. Calleja, J. García‐Pagán, 2017, Gastroenterology.

Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy.

X. Forns, J. Sánchez-Tapias, J. Calleja, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hemodynamic response to propranolol in patients with recurrent hepatitis C virus–related cirrhosis after liver transplantation: A case‐control study

X. Forns, J. García-Valdecasas, J. Bosch, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation

X. Forns, M. Navasa, J. García-Valdecasas, 2006, Hepatology.

EASL Clinical Practice Guidelines: Vascular diseases of the liver.

D. Valla, J. García‐Pagán, M. Senzolo, 2016, Journal of hepatology.

Next generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.

D. Colomer, M. López-Guerra, J. García‐Pagán, 2020, Journal of hepatology.

Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd‐Chiari syndrome

J. Bosch, J. García‐Pagán, J. Abraldes, 2006, Hepatology.

Budd-Chiari syndrome: a review by an expert panel.

D. Valla, H. Janssen, G. Mentha, 2003, Journal of hepatology.

Total effective vascular compliance in patients with cirrhosis. Effects of propranolol.

J. García‐Pagán, J. Bosch, E. Moitinho, 2002, Journal of hepatology.

Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis.

J. Roca, R. Rodríguez-Roisín, A. Agustí, 1990, The American review of respiratory disease.

Budd-Chiari Syndrome 13

J. Bosch, P. Tandon, J. García‐Pagán, 2011 .

Idiopathic Portal Hypertension (Portosinusoidal Disease)

J. García‐Pagán, V. Hernández-Gea, Á. García-Criado, 2018 .

Idiopathic noncirrhotic portal hypertension

D. Valla, J. García‐Pagán, J. Schouten, 2011, Hepatology.

Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding

M. Rudler, D. Thabut, N. Ganne-Carrié, 2021, Hepatology.

Portal Hypertensive Bleeding

J. García‐Pagán, V. Hernández-Gea, A. Cárdenas, 2019, Clinical Gastrointestinal Endoscopy.

Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study

V. de Lédinghen, A. de Gottardi, L. Rubbia‐Brandt, 2019, Hepatology.

J. Bosch, J. García‐Pagán, A. Cárdenas, 2017, Hepatology.

Nonendoscopic management of acute esophageal variceal bleeding

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2017 .

Refractory Variceal Bleeding: When First Endoscopy Fails, What Next?

J. García‐Pagán, V. Hernández-Gea, F. Turon, 2017 .

Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial

J. Bosch, J. García‐Pagán, A. Cárdenas, 2016, Hepatology.

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

J. Bosch, J. Calleja, J. García‐Pagán, 2016, Gastroenterology.

Management of Acute Variceal Bleeding in Patients with Cirrhosis: General Management, Drug Therapy, and Endoscopic Treatment

F. Nevens, P. Tandon, J. García‐Pagán, 2016 .

Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis

D. Valla, J. Bosch, C. Bureau, 2016, Hepatology.

The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique

J. Bosch, J. García‐Pagán, F. Torres, 2015, Hepatology.

TIPS: Primary Therapy or Rescue in Treatment of Acute Variceal Hemorrhage

J. García‐Pagán, V. Hernández-Gea, F. Turon, 2014 .

Idiopathic portal hypertension: Natural history and long‐term outcome

A. Berzigotti, J. García‐Pagán, R. Miquel, 2014, Hepatology.

PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Management of Gastric Varices

J. García‐Pagán, A. Cárdenas, M. Barrufet, 2014 .

Acute Variceal Bleeding

J. Bosch, J. García‐Pagán, E. Reverter, 2012, Seminars in Respiratory and Critical Care Medicine.

Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome.

D. Thabut, D. Luton, D. Valla, 2012, Journal of hepatology.

Chapter 45 – Portal and Splenic Vein Thrombosis

J. Bosch, J. García‐Pagán, S. Seijo, 2012 .

Management of an acute variceal bleeding episode

J. García‐Pagán, E. Reverter, 2012, Clinical liver disease.

The Treatment and Prevention of Variceal Bleeding

J. Bosch, J. García‐Pagán, J. Abraldes, 2011 .

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study

D. Valla, D. Vidaud, J. Trebicka, 2010, Hepatology.

Refractory acute variceal bleeding: what to do next?

A. Berzigotti, J. García‐Pagán, M. D'amico, 2010, Clinics in liver disease.

Should Prognostic Variables be Used to Direct Patient Management in the Acute Setting

J. García‐Pagán, M. D'amico, 2010 .

Primary prophylaxis of esophageal variceal bleeding in cirrhosis.

J. García‐Pagán, J. Bosch, J. Abraldes, 2008, Gastroenterologie clinique et biologique.

Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis

R. Makuch, R. Groszmann, A. Burroughs, 2007, Hepatology.

Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation.

J. Ayuso, J. Bosch, J. Calleja, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prevention of recurrent variceal bleeding.

A. Berzigotti, J. García‐Pagán, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Portal Hypertension and Gastrointestinal Bleeding

J. Bosch, A. Berzigotti, J. García‐Pagán, 2008, Seminars in liver disease.

Is it necessary to endoscopically screen all patients with hepatitis C and advanced fibrosis for esophageal varices?

J. García‐Pagán, 2007, Nature Clinical Practice Gastroenterology &Hepatology.

Endoscopic band ligation in the treatment of portal hypertension

J. Bosch, J. García‐Pagán, 2005, Nature Clinical Practice Gastroenterology &Hepatology.

Variceal and other portal hypertension related bleeding.

J. García‐Pagán, V. Hernández-Gea, S. Casu, 2013, Best practice & research. Clinical gastroenterology.

[Portal vein thrombosis].

J. García‐Pagán, S. Seijo-Ríos, 2010, Gastroenterologia y hepatologia.

Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial

J. Bosch, J. García‐Pagán, J. Bosch, 2009, Gut.

The Budd-Chiari syndrome.

D. Valla, H. Janssen, J. García‐Pagán, 2004, The New England journal of medicine.

Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension

A. de Gottardi, J. Bosch, A. Berzigotti, 2013, PloS one.

Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

A. de Gottardi, D. Semela, D. Valla, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Treatment of Acute Variceal Bleeding in 2021-When to Use Transjugular Intrahepatic Portosystemic Shunts?

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Clinics in liver disease.

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

M. Rudler, D. Thabut, F. Nevens, 2018, Hepatology.

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome.

D. Valla, J. Trebicka, E. Elias, 2010, Blood.

Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2013, Journal of Hepatology.

Contrast‐enhanced CT and liver surface nodularity for the diagnosis of porto‐sinusoidal vascular disorder: A case‐control study

M. Ronot, V. Paradis, V. Vilgrain, 2022, Hepatology.

Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury.

S. Friedman, J. García‐Pagán, J. Bosch, 2019, Journal of hepatology.

Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome.

D. Valla, J. Trebicka, H. Janssen, 2011, Journal of hepatology.

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

J. Bosch, R. Deulofeu, J. García‐Pagán, 2006, Hepatology.

Reply to: Correspondence on "Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis".

D. Colomer, J. García‐Pagán, F. Cervantes, 2020, Journal of hepatology.

Monitoring of HVPG during pharmacological therapy: Evidence in favor of the prognostic value of a 20% reduction

J. García‐Pagán, J. Bosch, 2004, Hepatology.

A histologic scoring system for prognosis of patients with alcoholic hepatitis.

R. Bataller, T. Roskams, T. Smyrk, 2014, Gastroenterology.

Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis

R. Bataller, V. Arroyo, Silvia Affò, 2013, Hepatology.

Inflammation and portal hypertension - the undiscovered country.

V. Shah, R. Moreau, R. Jalan, 2014, Journal of hepatology.

Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: Comparison with the effects on portal pressure

M. Navasa, J. Bosch, J. Bordas, 1988, Hepatology.

Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis

J. González-Navajas, F. Tomás-Barberán, J. García‐Pagán, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Influence of beta‐2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis

J. Bosch, R. Oliva, J. García‐Pagán, 2006, Hepatology.

Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route.

M. Manyalich, R. Gomis, I. Conget, 2006, Transplantation.

Thromboprophylaxis with heparin in hospitalized patients with cirrhosis: friend or foe

J. García‐Pagán, F. Cerini, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.

J. Bosch, J. García‐Pagán, E. Moitinho, 2002 .

Randomized comparison of long‐term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis

J. Bosch, J. García‐Pagán, E. Moitinho, 2002, Hepatology.

Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis☆☆☆

J. García‐Pagán, J. Bosch, E. Moitinho, 2001 .

Measurement of Azygos Blood Flow

J. Bosch, J. García‐Pagán, F. Feu, 1991 .

Microparticles and paracrine signaling in portal hypertension: crucial conversations or idle chat?

V. Shah, J. García‐Pagán, 2012, Gastroenterology.

Acute and long‐term effects of inhaled iloprost in portopulmonary hypertension

J. Roca, J. García‐Pagán, J. Bosch, 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension.

J. Barberà, J. Roca, R. Rodríguez-Roisín, 1999, The European respiratory journal.

Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis.

P. Pizcueta, J. Rodés, J. García‐Pagán, 1994, Journal of hepatology.

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

M. Navasa, J. Rodés, J. García‐Pagán, 1990, Journal of hepatology.

Effects of end‐to‐side portacaval shunt and distal splenorenal shunt on systemic and pulmonary haemodynamics in patients with cirrhosis

J. Visa, J. Bosch, J. García‐Pagán, 1999, Journal of gastroenterology and hepatology.

Etiology, management, and outcome of the Budd-Chiari syndrome.

F. Rosendaal, D. Valla, J. Trebicka, 2009, Annals of internal medicine.

Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.

C. Chagneau, D. Valla, H. Janssen, 2009, Journal of hepatology.

TIPS is a useful long‐term derivative therapy for patients with Budd‐Chiari syndrome uncontrolled by medical therapy

J. Rodés, J. García‐Pagán, J. Bosch, 2002, Hepatology.

AASLD Program

Frederik, G. Gores, A. Jegga, 2007 .

Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis.

R. Deulofeu, J. García‐Pagán, J. Bosch, 2013, American journal of physiology. Gastrointestinal and liver physiology.

The Splanchnic Circulation in Cirrhosis

J. Bosch, J. García‐Pagán, 2007 .

Bone morphogenetic protein receptor 2 in patients with idiopathic portal hypertension

A. de Gottardi, M. Milá, J. Bosch, 2012, Journal of cellular and molecular medicine.

Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats.

M. Mejías, J. Bosch, Mercedes Fernandez, 2006, Journal of hepatology.

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis

J. Bosch, J. García‐Pagán, R. Francés, 2010, Hepatology.

Animal models of portal hypertension.

J. García‐Pagán, J. Abraldes, M. Pasarín, 2006, World journal of gastroenterology.

Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension.

J. Bosch, J. García‐Pagán, M. Hernández‐Guerra, 2005, Journal of clinical gastroenterology.

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

J. Rodés, M. Mejías, J. Bosch, 2005, Journal of hepatology.

LIVER NAD ( P ) H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats

M. Mejías, J. Bosch, Mercedes Fernandez, 2007 .

5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes.

J. Rodés, J. Bosch, J. Clària, 2002, Gastroenterology.

Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia.

M. Clemens, J. Zhang, J. García‐Pagán, 1999, Shock.

Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis.

A. de Gottardi, R. Salem, F. Leebeek, 2019, Journal of hepatology.

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.

D. Colomer, D. Valla, N. Casadevall, 2017, Journal of hepatology.

Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis

D. Valla, J. Trebicka, H. Janssen, 2015, Haematologica.

Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis.

D. Colomer, J. García‐Pagán, V. Hernández-Gea, 2015, Journal of hepatology.

Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites

W. Jiménez, V. Arroyo, J. Rodés, 1994, Hepatology.

An overview of current treatment methods for Budd–Chiari syndrome

J. García‐Pagán, S. Seijo, 2014 .

Porto-sinusoidal vascular disease: proposal and description of a novel entity.

V. Vilgrain, A. de Gottardi, L. Rubbia‐Brandt, 2019, The lancet. Gastroenterology & hepatology.

Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension.

A. Berzigotti, J. García‐Pagán, R. Miquel, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis

J. Rodés, J. Bosch, A. Berzigotti, 2003, Hepatology.

Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome.

C. Nicolau, X. Bargalló, J. García‐Pagán, 2003, AJR. American journal of roentgenology.

Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.

W. Jiménez, V. Arroyo, F. Rivera, 1992, Gastroenterology.

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

M. Trauner, P. Ferenci, P. Schwabl, 2019, Hepatology.

Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.

W. Jiménez, V. Arroyo, J. Rodés, 1995, Hepatology.

Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation

C. Strassburg, J. Trebicka, M. Merli, 2021, JHEP reports : innovation in hepatology.

Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis.

J. Bosch, P. Tandon, A. Berzigotti, 2010, Journal of hepatology.

Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.

M. Rudler, D. Thabut, F. Nevens, 2021, Journal of hepatology.

Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease

J. Bosch, C. Peralta, J. Lozano, 2019, Aging and disease.

Where does TIPS fit in the management of patients with cirrhosis?

J. García‐Pagán, M. Mandorfer, G. Garcia‐Tsao, 2020, JHEP reports : innovation in hepatology.

Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review

J. García‐Pagán, V. Hernández-Gea, M. Mandorfer, 2020, Seminars in Liver Disease.

Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring?

J. García‐Pagán, V. Hernández-Gea, M. Mandorfer, 2019, Current Hepatology Reports.

Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies

J. L. Rosa, J. Bosch, J. García‐Pagán, 2017, Scientific Reports.

[Animal models for the study of portal hypertension].

J. García‐Pagán, J. Abraldes, 2006, Gastroenterologia y hepatologia.

Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis

V. Paradis, R. Moreau, D. Valla, 2018, Hepatology.

Acute variceal bleeding: risk stratification and management (including TIPS)

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2018, Hepatology International.

Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

L. Fuccio, J. García‐Pagán, Robyn Rosasco, 2022, Endoscopy.

Budd-Chiari Syndrome: Hepatic Venous Outflow Tract Obstruction

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Vascular Disorders of the Liver.

Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis

J. García‐Pagán, Arturo Pereira, V. Hernández-Gea, 2020, Annals of Hematology.

Congenital antithrombin deficiency in patients with splanchnic vein thrombosis

J. Corral, V. Vicente, J. García‐Pagán, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Portal cholangiopathy: radiological classification and natural history

J. García‐Pagán, J. Bosch, S. Seijo, 2011, Gut.

Portal hypertension: Nonselective β-blockers in patients with refractory ascites

J. García‐Pagán, 2011, Nature Reviews Gastroenterology &Hepatology.

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

M. Rudler, D. Thabut, F. Nevens, 2022, Gut.

Current knowledge and management of portal vein thrombosis in cirrhosis.

J. García‐Pagán, M. Senzolo, G. Garcia‐Tsao, 2021, Journal of hepatology.

New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis

J. García‐Pagán, V. Hernández-Gea, M. Burrel, 2020, Seminars in Thrombosis and Hemostasis.

Budd-Chiari Syndrome: Anticoagulation, TIPS, or Transplant

J. García‐Pagán, M. Magaz, G. Soy, 2020, Current Hepatology Reports.

Risk of bleeding in cirrhotic patients treated with rivaroxaban

A. de Gottardi, J. García‐Pagán, 2017, Liver international : official journal of the International Association for the Study of the Liver.

The anticoagulant efficacy of rivaroxaban may be attenuated in cirrhotic patients

A. de Gottardi, J. García‐Pagán, 2017, Liver international : official journal of the International Association for the Study of the Liver.

The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins.

G. Garcı́a-Cardeña, J. Bosch, J. García‐Pagán, 2013, Journal of hepatology.

Molecular abnormalities in portal hypertension: diagnostic, prognostic and therapeutic implications

J. Bosch, J. García‐Pagán, J. Abraldes, 2012 .

Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis

W. Jiménez, V. Arroyo, Mercedes Fernandez, 1995, Hepatology.

Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.

R. Makuch, R. Groszmann, A. Burroughs, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Propranolol plus placebo versus propranolol plus isosorbide‐5‐mononitrate in the prevention of a first variceal bleed: A double‐blind RCT

J. Calleja, J. García‐Pagán, J. Genescà, 2003, Hepatology.

Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.

J. Calleja, J. García‐Pagán, J. Genescà, 2001, Gastroenterology.

Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.

J. García‐Pagán, J. Bosch, E. Moitinho, 2001, Gastroenterology.

Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis

R. Moreau, R. Jalan, J. Bosch, 2012, European Journal of Clinical Pharmacology.

Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study

F. Nevens, S. Sarin, D. Valla, 2020, Hepatology.

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension

H. Møller, H. Grønbaek, J. García‐Pagán, 2021, Frontiers in Physiology.

Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.

J. Bosch, M. Ávila, J. García‐Pagán, 2016, Journal of hepatology.

BASIC AND TRANSLATIONAL — LIVER Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension

J. Bosch, J. García‐Pagán, J. Gracia‐Sancho, 2022 .

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

M. Rudler, D. Thabut, F. Nevens, 2020, Journal of hepatology.

Pregnancy in idiopathic non-cirrhotic portal hypertension: A multicentric study on maternal and fetal management and outcome.

D. Valla, C. Bureau, E. de Raucourt, 2018, Journal of hepatology.

Failure to control variceal bleeding: definition matters.

C. Bureau, J. García‐Pagán, A. Baiges, 2021, Journal of hepatology.

Reply to: "Pre-emptive TIPS for acute variceal bleeding in acute-on-chronic liver failure: Is there enough evidence for a routine recommendation?": pTIPS for variceal bleeding in ACLF patients: when and why?

J. Trebicka, J. Bosch, J. García‐Pagán, 2020, Journal of hepatology.

Non-invasive tests for clinically significant portal hypertension after HCV cure.

H. Yoshiji, X. Forns, E. Tsochatzis, 2022, Journal of hepatology.

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.

J. Trebicka, S. Kubicek, B. Hofer, 2022, Journal of hepatology.

Editorial: measuring inflammatory and fibrotic components of portal hypertension – a non‐invasive hepatic venous pressure gradient? Authors’ reply

H. Møller, T. Sandahl, H. Grønbæk, 2016, Alimentary pharmacology & therapeutics.

Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis.

J. Bosch, Hélène Larrue, C. Bureau, 2022, Journal of hepatology.

Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin.

J. González-Navajas, J. Bosch, J. García‐Pagán, 2008, Journal of hepatology.

Measurement of portal pressure and its role in the management of chronic liver disease.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2006, Seminars in liver disease.

Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension.

E. Bouza, P. Muñoz, J. García‐Pagán, 2004, Diagnostic microbiology and infectious disease.

Effects of low‐sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis

P. Pizcueta, V. Arroyo, J. Rodés, 1994, Hepatology.

NCX-1000, a Nitric Oxide–Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study

J. Bosch, C. Gagnon, A. Berzigotti, 2010, The American Journal of Gastroenterology.

Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.

J. Rodés, J. Bosch, J. García‐Pagán, 1991, Journal of hepatology.

Session 5 ‒ Primary Prophylaxis

J. García‐Pagán, N. Grace, 2008 .

Non-selective beta-blockers in the prevention of first variceal bleeding. Is there any definite alternative?

J. García‐Pagán, 2002, Journal of hepatology.

Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.

J. Bosch, J. Calleja, J. García‐Pagán, 1998, Gastroenterology.

What else we need

J. Bosch, J. García‐Pagán, J. Turnés, 2004 .

Portal vein thrombosis: a predictable milestone in cirrhosis?

D. Valla, J. García‐Pagán, 2009, Journal of hepatology.

Portal vein thrombosis: A predictable milestone in cirrhosis? q

D. Valla, J. García‐Pagán, 2009 .

Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.

J. Rodés, J. García‐Pagán, J. Bosch, 1996, Journal of hepatology.

Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy

J. Bosch, J. Panés, J. Bordas, 1993, Hepatology.

Lack of Correlation Between Preoperative and Intraoperative Liver Hemodynamics: A Descriptive Analysis

C. Fondevila, J. Fuster, J. García-Valdecasas, 2014, Transplantation.

Ascites after liver transplantation

L. Grande, J. Fuster, J. García-Valdecasas, 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Treatment of Acute Bleeding

L. Laine, P. Kamath, J. Vinel, 2010 .

Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

H. Rousseau, J. Vinel, C. Bureau, 2004, Gastroenterology.

Endoscopic hemostasis in acute esophageal variceal bleeding.

J. García‐Pagán, V. Hernández-Gea, A. Cárdenas, 2014, Gastroenterology clinics of North America.

Best Practice & Research Clinical Gastroenterology

J. García‐Pagán, S. Casu, F. Turon, 2013 .

Prevention of variceal rebleeding

J. García‐Pagán, J. Bosch, 2003, The Lancet.

Lymphocyte beta-2 adrenoceptors (LAR-B2), plasma catecholamines and haemodynamic response to propranolol (PROP) in patients with cirrhosis and portal hypertension.

P. Pizcueta, F. Rivera, J. Rodés, 1989 .

Enhanced release of vasoconstrictors

J. García‐Pagán, 2004 .

Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis

R. Moreau, R. Jalan, J. Bosch, 2012, European Journal of Clinical Pharmacology.

Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes.

D. Luton, D. Valla, J. Bernuau, 2009, Journal of hepatology.

PTFE‐covered stents improve TIPS patency in Budd‐Chiari syndrome

S. Olliff, J. Bosch, E. Elias, 2004, Hepatology.

Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt

J. García‐Pagán, M. Magaz, 2021, Hepatology International.

Portal Hypertension Reverses Following Successful Antiviral Treatment for HCV: Fact or Fiction?

X. Forns, J. García‐Pagán, S. Lens, 2018, Current Hepatology Reports.

Anticoagulation in cirrhosis: Ready … set … wait!

J. García‐Pagán, S. Seijo, 2013, Hepatology.

Other clinical studyNoninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis

J. Rodés, J. Bosch, Mercedes Fernandez, 1995 .

Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference

H. Büller, L. Bechmann, D. Valla, 2018, Thrombosis and Haemostasis.

TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.

D. Valla, S. Olliff, A. Nicolini, 2008, Gastroenterology.

Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension

J. Bosch, J. García‐Pagán, S. Seijo, 2011, Gut.

Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2015, Journal of hepatology.

Transjugular liver biopsy.

J. García‐Pagán, R. Miquel, V. Hernández-Gea, 2014, Clinics in liver disease.

The clinical use of HVPG measurements in chronic liver disease

J. Bosch, A. Berzigotti, J. García‐Pagán, 2009, Nature Reviews Gastroenterology &Hepatology.

Noninvasive Prediction of Clinically Significant Portal Hypertension and Esophageal Varices in Patients With Compensated Liver Cirrhosis

C. Nicolau, J. Bosch, A. Berzigotti, 2008, The American Journal of Gastroenterology.

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

Ramon Planas, David Patch, R. Makuch, 2007, Gastroenterology.

Hemodynamic response to pharmacological treatment of portal hypertension and long‐term prognosis of cirrhosis

J. Rodés, J. Bosch, I. Tarantino, 2003, Hepatology.

Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

Zaibo Jiang, M. Rudler, D. Thabut, 2020, Gastroenterology.

Reply:

J. García‐Pagán, V. Hernández-Gea, 2019, Hepatology.

Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study.

F. Nevens, T. Sauerbruch, W. Laleman, 2012, Journal of hepatology.

Early use of TIPS in patients with cirrhosis and variceal bleeding.

F. Nevens, W. Laleman, J. Bosch, 2010, The New England journal of medicine.

TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial

J. García‐Pagán, J. Bosch, E. Moitinho, 2002, Hepatology.

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

X. Forns, M. Navasa, J. Bosch, 2007, Gastroenterology.

[Diagnosis and treatment of portal thrombosis in liver cirrhosis].

J. García‐Pagán, S. Seijo, Á. García-Criado, 2012, Gastroenterologia y hepatologia.

elastography in clinically doubtful cirrhosis q

J. Bosch, P. Tandon, A. Berzigotti, 2010 .

Complications of cirrhosis. I. Portal hypertension.

J. Bosch, J. García‐Pagán, 2000, Journal of hepatology.

Carvedilol, a new nonselective beta‐blocker with intrinsic anti‐alpha1‐adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

J. García‐Pagán, J. Bosch, E. Moitinho, 1999, Hepatology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, A. Berzigotti, J. García‐Pagán, 2017 .

Idiopathic noncirrhotic portal hypertension in HIV-infected patients.

J. García‐Pagán, P. Chang, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Portal hypertension: recommendations for evaluation and treatment: consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases(CIBERehd)].

J. Calleja, A. Berzigotti, J. García‐Pagán, 2012, Gastroenterologia y hepatologia.

Baveno VII - Renewing consensus in portal hypertension.

H. Yoshiji, J. Fallowfield, V. Paradis, 2021, Journal of hepatology.

Early use of TIPS in patients with cirrhosis and variceal bleeding

J. Bosch, J. García‐Pagán, Jaime Bosch, 2010, Annals of Internal Medicine.

Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.

A. Berzigotti, J. García‐Pagán, J. Bosch, 2009, Journal of hepatology.

Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature

J. Falcón-Pérez, C. Fondevila, J. Bosch, 2021, Cancers.

Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021

P. Siersema, T. Baron, L. Fuccio, 2021, Endoscopy.

Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Cascade Guideline

C. Hassan, P. Vilmann, T. Ponchon, 2019, Endoscopy International Open.

Role of gap junctions modulating hepatic vascular tone in cirrhosis

E. Salido, J. Bosch, E. Quintero, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.

J. Lozano, J. García‐Pagán, S. Seijo, 2021, Journal of hepatology.

Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

D. Valla, R. Superina, J. García‐Pagán, 2020, Hepatology.

[Portal vein thrombosis].

J. García‐Pagán, S. Seijo, Susana Seijo, 2018, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Management of gastric varices.

J. García‐Pagán, A. Cárdenas, M. Barrufet, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis

J. Balust, G. Martínez-Pallí, A. Berzigotti, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Unexpected disappearance of portal cavernoma on long-term anticoagulation.

J. García‐Pagán, V. Hernández-Gea, Á. García-Criado, 2014, Journal of hepatology.

NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats

M. Mejías, J. Bosch, Mercedes Fernandez, 2006, Gut.

Congenital Extrahepatic Portosystemic Shunts: Abernethy Malformation

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Vascular Disorders of the Liver.

Idiopathic Portal Hypertension in Patients With HIV Infection Treated With Highly Active Antiretroviral Therapy

J. Blanco, M. Laguno, J. Bosch, 2009, The American Journal of Gastroenterology.

Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.

J. Bosch, M. Pinzani, A. Berzigotti, 2013, Gastroenterology.

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet‐derived growth factor blockade in rats

M. Mejías, E. García-Pras, R. Méndez, 2007, Hepatology.

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.

R. Makuch, R. Groszmann, A. Burroughs, 2009, Journal of hepatology.

Pharmacological Reduction of Portal Pressure and Long-Term Risk of First Variceal Bleeding in Patients with Cirrhosis

J. Bosch, J. García‐Pagán, J. Abraldes, 2006, The American Journal of Gastroenterology.

Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis

W. Ageno, A. de Gottardi, M. Di Nisio, 2021, Thrombosis and Haemostasis.

Anticoagulant therapy for splanchnic vein thrombosis: A systematic review and meta-analysis.

W. Ageno, M. Di Nisio, E. Porreca, 2020, Blood.

Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus–related cirrhosis

Rosa Gilabert, Jaume Bosch, J. García‐Pagán, 1999, Hepatology.

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

C. Strassburg, D. Toth, J. Trebicka, 2020, Journal of hepatology.

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

X. Forns, M. Navasa, J. García‐Pagán, 2018, Hepatology.

The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study

J. García‐Pagán, V. Hernández-Gea, T. Lisman, 2022, Journal of thrombosis and haemostasis : JTH.

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

W. Ageno, A. de Gottardi, M. Di Nisio, 2022, Blood advances.

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

M. Casas, J. García‐Pagán, J. Genescà, 2015, Hepatology.

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

Ramon Planas, David Patch, Andrew K Burroughs, 2005, The New England journal of medicine.

Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

J. García‐Pagán, V. Hernández-Gea, A. Albillos, 2021, Clinical Gastroenterology and Hepatology.

Imaging in clinical decision-making for portal vein thrombosis

A. Berzigotti, J. García‐Pagán, Á. García-Criado, 2014, Nature Reviews Gastroenterology &Hepatology.

Good long‐term outcome of Budd‐Chiari syndrome with a step‐wise management

D. Valla, J. Trebicka, E. Elias, 2013, Hepatology.

Endoscopic Cyanoacrylate Injection Versus Balloon‐Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial

Jinlin Yang, Xuefeng Luo, J. García‐Pagán, 2021 .

Functional aspects on the pathophysiology of portal hypertension in cirrhosis.

J. García‐Pagán, J. Bosch, J. Gracia-Sancho, 2012, Journal of hepatology.

Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.

Mercedes Fernandez, J. García‐Pagán, J. Bosch, 2010, Journal of hepatology.

Reply to: ''Splenic artery aneurysms, portal hypertension and pregnancy".

C. Bureau, F. Oberti, J. García‐Pagán, 2019, Journal of hepatology.

Prognosis of acute variceal bleeding: Is being on beta‐blockers an aggravating factor? A short‐term survival analysis

J. Bosch, A. Berzigotti, J. García‐Pagán, 2015, Hepatology.

KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins

G. Garcı́a-Cardeña, J. Bosch, J. García‐Pagán, 2014, Gut.

Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis

P. Quaretti, J. Trebicka, J. García‐Pagán, 2021, Hepatology.

Portal Hypertension Secondary to Myelofibrosis: A Study of Three Cases

J. Bosch, J. García‐Pagán, R. Miquel, 2005, The American Journal of Gastroenterology.

Sonography of Budd-Chiari syndrome.

C. Nicolau, J. Ayuso, X. Bargalló, 2006, AJR. American journal of roentgenology.

Aphasia in a patient with acute hepatic encephalopathy associated with multifocal cortical brain lesions.

E. Muñoz, J. García‐Pagán, J. Berenguer, 2016, Neurologia.

Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy

J. Bosch, C. Peralta, J. García‐Pagán, 2016, Scientific Reports.

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis

R. Bataller, V. Arroyo, Silvia Affò, 2015, Hepatology.

Terutroban, a TP‐receptor antagonist, reduces portal pressure in cirrhotic rats

J. García‐Pagán, J. Bosch, A. Rodríguez-Vilarrupla, 2013, Hepatology.

Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.

J. Rodés, J. Bosch, J. García‐Pagán, 1998, Gastroenterology.

Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis.

J. García‐Pagán, M. Senzolo, E. Reverter, 2020, Journal of hepatology.

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis.

D. Valla, J. Trebicka, H. Janssen, 2011, Blood.

Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

J. Lozano, A. Berzigotti, C. Alonso, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension

J. Lozano, A. Berzigotti, C. Alonso, 2013, The American Journal of Gastroenterology.

Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy.

M. Trauner, P. Ferenci, P. Schwabl, 2019, Hepatology.

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.

Angelo Luca, G. D’Amico, J. Bosch, 2006, Gastroenterology.

Calculating Hepatic Venous Pressure Gradient: Feel Free to Stay Free.

J. Bosch, J. García‐Pagán, 2016, Journal of vascular and interventional radiology : JVIR.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

A. de Gottardi, F. Nevens, J. Trebicka, 2022, Transplantation.

Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors.

J. Bruix, J. Bosch, A. Berzigotti, 2012, Journal of hepatology.

Impact of prior portosystemic shunt procedures on outcome of liver transplantation.

J. Fuster, J. García-Valdecasas, J. Bosch, 2005, Surgery.

Trials and Tribulations: The Prevention of Variceal Rebleeding.

J. García‐Pagán, D. Patch, 2015, Gastroenterology.

Incidence and Natural Course of Portal Vein Thrombosis in Cirrhosis

J. García‐Pagán, M. Senzolo, 2013, The American Journal of Gastroenterology.

Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis.

R. Groszmann, J. Rodés, J. García‐Pagán, 1997, Gastroenterology.

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

R. Groszmann, A. Burroughs, J. Bosch, 2011, Hepatology.

Role and Modulation of Nitric Oxide in the Cirrhotic Liver

J. Bosch, J. García‐Pagán, J. Gracia‐Sancho, 2014 .

Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta‐analysis

B. Sharma, S. Sarin, J. Bosch, 2017, Hepatology.

Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

M. Poca, J. Falcón-Pérez, J. Bosch, 2021, JHEP reports : innovation in hepatology.

Physiology of the Splanchnic and Hepatic Circulations

J. Bosch, J. García‐Pagán, G. Mehta, 2011 .

Cardiovascular Risk Factors and Systemic Endothelial Function in Patients With Cirrhosis

J. Bosch, A. Berzigotti, J. García‐Pagán, 2013, The American Journal of Gastroenterology.

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.

J. Bosch, J. García‐Pagán, J. Abraldes, 2009, Gastroenterology.

Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis

D. Fan, G. Han, J. García‐Pagán, 2014, Journal of clinical gastroenterology.

J. García‐Pagán, V. Hernández-Gea, 2019, Hepatology.

Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.

S. Sarin, J. Bosch, J. García‐Pagán, 2015, American journal of physiology. Gastrointestinal and liver physiology.

Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.

X. Forns, W. Jiménez, M. Navasa, 2010, Gastroenterology.

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

Rosa Gilabert, Jaume Bosch, Vicente Arroyo, 1998, Hepatology.

Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis.

C. Nicolau, J. Bosch, A. Berzigotti, 2011, Journal of hepatology.

Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury.

J. Bosch, C. Peralta, J. García‐Pagán, 2017, Journal of hepatology.

Fibrinogen γ’ and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis

D. Valla, J. Trebicka, H. Janssen, 2013, Thrombosis and Haemostasis.

Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd‐Chiari patients

J. García‐Pagán, J. Bosch, M. Real, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[Recommendations for the diagnosis and treatment of patients with Budd-Chiari syndrome].

J. García‐Pagán, M. Hernández‐Guerra, 2004, Gastroenterologia y hepatologia.

Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease.

X. Forns, J. Trebicka, W. Laleman, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Autoimmune biomarkers in porto‐sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology

M. Juan, J. García‐Pagán, S. Seijo, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Management of the major complications of cirrhosis: Beyond guidelines.

J. García‐Pagán, M. Senzolo, S. Montagnese, 2021, Journal of hepatology.

A simple nomogram identifies patients with refractory ascites with worse outcome after transjugular intrahepatic portosystemic shunt

J. García‐Pagán, V. Hernández-Gea, A. Albillos, 2021, European journal of gastroenterology & hepatology.

Endoscopic Cyanoacrylate Injection Versus Balloon‐Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial

Xuefeng Luo, J. García‐Pagán, Xiaoze Wang, 2021, Hepatology.

Utility of Color Doppler Ultrasonography Predicting TIPS Dysfunction

J. Aponte, J. Bosch, A. Berzigotti, 2005, The American Journal of Gastroenterology.

Patients whose first episode of bleeding occurs while taking a β-blocker have high long-term risks of rebleeding and death.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta‐analysis

F. Piscaglia, J. Trebicka, M. Thiele, 2020, Liver international : official journal of the International Association for the Study of the Liver.

The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis

H. Møller, T. Sandahl, H. Grønbæk, 2016, Alimentary pharmacology & therapeutics.

Clinical Manifestations and Management of Bleeding Episodes in Cirrhotics

J. Bosch, J. García‐Pagán, J. Abraldes, 2008 .

Value of transient elastography measured with fibroscan in predicting the outcome of hepatic resection for hepatocellular carcinoma.

J. Bruix, A. Berzigotti, J. García‐Pagán, 2015, Annals of surgery.

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

M. Poca, J. Calleja, J. Lozano, 2023, Hepatology.

Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.

S. Chevret, D. Valla, F. Piscaglia, 2023, Journal of hepatology.

Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension

D. Valla, J. Trebicka, J. Nault, 2016, Hepatology.

Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators (J Hepatol 1985; 1: 325–337)

J. García‐Pagán, J. Bosch, 2004 .

Insulin resistance in patients with cirrhosis and portal hypertension.

I. Conget, A. Berzigotti, J. García‐Pagán, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.

J. Bosch, J. García‐Pagán, J. Gracia‐Sancho, 2018, Gastroenterology.

Portal vein thrombosis: yes or no on anticoagulation therapy.

J. García‐Pagán, V. Hernández-Gea, F. Turon, 2018, Current opinion in organ transplantation.

Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies

J. L. Rosa, J. Bosch, J. García‐Pagán, 2017, Scientific Reports.

TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.

M. Rudler, D. Thabut, T. Sauerbruch, 2023, Journal of hepatology.

Effects of ritanserin, a selective and specific S2‐serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long‐term bile duct ligation

P. Pizcueta, J. Rodés, J. Bosch, 1993, Hepatology.

Portal hypertension.

M. Navasa, J. Rodés, J. García‐Pagán, 1989, The Medical clinics of North America.

Role of JAK 2 Mutation Detection in Budd-Chiari Syndrome (BCS) and Portal Vein Thrombosis (PVT) Associated to MPD.

S. Chevret, D. Valla, P. Fenaux, 2006 .

Obstruction of the Portal Vein

J. Bosch, J. García‐Pagán, M. Hernández‐Guerra, 2008 .

Stroke Volume Response to Liver Graft Reperfusion Stress in Cirrhotic Patients

J. García-Valdecasas, J. Balust, G. Martínez-Pallí, 2014, World Journal of Surgery.

Risk of non‐tumoural portal vein thrombosis in patients with HCV‐induced cirrhosis after sustained virological response

X. Forns, G. Casanovas, J. García‐Pagán, 2021, Liver international : official journal of the International Association for the Study of the Liver.

[87] EFFICACY OF ANTIVIRAL THERAPY ON DISEASE PROGRESSION IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A RANDOMIZED CONTROLLED STUDY

X. Forns, M. Navasa, J. Bosch, 2007 .

A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding

J. Bosch, A. Berzigotti, J. García‐Pagán, 2020, Hepatology.

Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.

W. Jiménez, V. Arroyo, J. García‐Pagán, 2004, Journal of hepatology.

A major research gap: the use of anticoagulants in cirrhosis.

J. García‐Pagán, M. Senzolo, 2023, Journal of hepatology.

M. Rudler, D. Thabut, F. Nevens, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Rivaroxaban Reduces Portal Hypertension in Cirrhotic Rats by Deactivating Hepatic Stellate Cells and Reducing Intrahepatic Microthrombosis

M. Ávila, J. García‐Pagán, J. Bosch, 2016 .

Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.

J. García‐Pagán, J. Bosch, F. Torres, 2017, Gastroenterology.

Session 4: Primary Prophylaxis for Variceal Bleeding

N. Chalasani, R. Moreau, J. García‐Pagán, 2007 .

Clinical events following TIPS: Correlation with hemodynamic findings

J. Rodés, J. García‐Pagán, J. Bosch, 1995 .

106 EFFICACY AND SAFETY OF ANTICOAGULATION IN PATIENTS WITH CIRRHOSIS AND PORTAL VEIN THROMBOSIS

J. García‐Pagán, J. Bosch, S. Seijo, 2012 .

Letter: improve survival after variceal bleeding in cirrhosis—place pTIPS as early as possible after index bleed

M. Rudler, D. Thabut, J. García‐Pagán, 2023, Alimentary pharmacology & therapeutics.

Portal hypertension and gastrointestinal bleeding.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2008, Seminars in liver disease.

Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: Results of a randomised controlled trial

J. García‐Pagán, J. Bosch, C. Villanueva, 2023, JHEP reports : innovation in hepatology.

Predicting Heart Failure After TIPS: Still More Questions Than Answers

J. García‐Pagán, A. Baiges, 2019, Hepatology.

Influence of Pharmacological Agents on Portal Hemodynamics: Basis for Its Use in the Treatment of Portal Hypertension

J. Bosch, J. García‐Pagán, E. Moitinho, 1999, Seminars in liver disease.

Letter: improve survival! Place early pre-emptive TIPSS in high-risk variceal bleeders.

J. Trebicka, C. Bureau, H. Grønbæk, 2020, Alimentary pharmacology & therapeutics.

Preemptive TIPS in Child-Pugh C patients.

J. García‐Pagán, V. Hernández-Gea, 2019, Hepatology.

[Early transjugular intrahepatic portosystemic shunt: When, how and in whom?].

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2016, Gastroenterologia y hepatologia.

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

J. Bruix, J. Visa, J. Fuster, 1996, Gastroenterology.

Pathophysiology of portal hypertension.

P. Pizcueta, J. Bosch, Mercedes Fernandez, 1992, Gastroenterology clinics of North America.

590 ASSESSMENT OF SYSTEMIC ENDOTHELIAL FUNCTION IN PATIENTS WITH CIRRHOSIS: COMPARISON BETWEEN PERIPHERAL ARTERIAL TONOMETRY (PAT) AND BRACHIAL ARTERY VASODILATATION BY ULTRASOUND (BAUS)

J. Bosch, A. Berzigotti, J. García‐Pagán, 2011 .

Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites

W. Jiménez, V. Arroyo, J. Rodés, 1994, Hepatology.

Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis.

P. Pizcueta, J. Rodés, J. Bosch, 1993, Gastroenterology.

Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension.

J. Barberà, J. Roca, R. Rodríguez-Roisín, 1996, Gastroenterology.

Reply Letter 17‐2110.R2

J. García‐Pagán, V. Hernández-Gea, 2018 .

Hyperintense globus pallidus on T1‐weighted MRI in cirrhotic patients is associated with severity of liver failure

E. Tolosa, J. Pujol, J. Rodés, 1993, Neurology.

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

R. Groszmann, A. Burroughs, J. Bosch, 2002, Gut.

Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

C. Hassan, P. Vilmann, T. Ponchon, 2016, Endoscopy.

Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients

A. de Gottardi, J. Bosch, J. García‐Pagán, 2008, Alimentary pharmacology & therapeutics.

Medical treatment of portal hypertension.

J. Bosch, J. García‐Pagán, J. García-Pagán, 2000, Bailliere's best practice & research. Clinical gastroenterology.

New approaches in the pharmacologic treatment of portal hypertension.

P. Pizcueta, J. Rodés, J. Bosch, 1993, Journal of hepatology.

Primary Budd-Chiari Syndrome.

J. García‐Pagán, Dominique-Charles Valla, 2023, The New England journal of medicine.

Simvastatin Attenuates Liver Injury in Rodents with Biliary Cirrhosis Submitted to Hemorrhage/Resuscitation

J. Bosch, J. Lozano, J. García‐Pagán, 2017, Shock.

Transjugular liver biopsy in BMT.

A. Grañena, J. Sierra, M. Navasa, 1993, Bone marrow transplantation.

Mitochondria‐targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats

M. Murphy, R. Deulofeu, J. García‐Pagán, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Non‐invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response

F. Nigsch, X. Forns, C. Ukomadu, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Combination of MELD and lactate predicts death in patients treated with salvage TIPS for refractory variceal bleeding.

M. Rudler, D. Thabut, N. Ganne-Carrié, 2021, Hepatology.

Reply to: "Calreticulin mutations and their importance in Budd-Chiari syndrome".

D. Valla, J. García‐Pagán, C. Marzac, 2017, Journal of hepatology.

Letter to the Editor: Salvage TIPS in Patients With Cirrhosis With Variceal Bleeding: MELD, Lactates, and “à la Carte” Decision

D. Thabut, C. Bureau, J. García‐Pagán, 2021 .

The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices.

R. Groszmann, J. Rodés, J. García‐Pagán, 1997, Gastroenterology.

Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference

H. Büller, L. Bechmann, D. Valla, 2018, Thrombosis and Haemostasis.

Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy

J. Bosch, J. Panés, J. Bordas, 1993, Hepatology.

Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis.

R. Groszmann, B. Sharma, S. Sarin, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

An early decission for PTFE-TIPS improves survival in high risk cirrhotic patients admitted with an acute variceal bleeding. A multicenter RCT

F. Nevens, W. Laleman, J. Vinel, 2008 .

992 AN EARLY DECISION FOR PTFE-TIPS IMPROVES SURVIVAL IN HIGH RISK CIRRHOTIC PATIENTS ADMITTED WITH AN ACUTE VARICEAL BLEEDING. A MULTICENTER RCT

F. Nevens, T. Sauerbruch, W. Laleman, 2008 .

Long‐term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: Importance of reversal of portal blood flow

Rosa Gilabert, L. Grande, J. Visa, 1992, Hepatology.

Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury.

S. Friedman, J. García‐Pagán, J. Bosch, 2019, Journal of hepatology.

Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.

S. Sarin, J. Bosch, J. García‐Pagán, 2015, American journal of physiology. Gastrointestinal and liver physiology.

Liver: Can we identify failure to control acute variceal bleeding?

J. García‐Pagán, V. Hernández-Gea, 2014, Nature Reviews Gastroenterology &Hepatology.

3. Management of Portal Hypertension

J. Bosch, J. García‐Pagán, J. Abraldes, 2012 .

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis

R. Bataller, V. Arroyo, Silvia Affò, 2015, Hepatology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, J. García‐Pagán, J. Genescà, 2017, Gastroenterologia y hepatologia.

EASL Clinical Practice Guidelines: Vascular diseases of the liver q

J. García‐Pagán, M. Senzolo, Dominique-Charles Valla, 2015 .

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis

J. Bosch, J. García‐Pagán, R. Francés, 2010, Hepatology.

EASL-ERN position paper on liver involvement in patients with Fontan-type circulation.

H. Verkade, J. García‐Pagán, P. Rautou, 2023, Journal of hepatology.

MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up

J. García‐Pagán, S. Seijo, V. Hernández-Gea, 2023, Liver Cancer.

Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis

Silvia Affò, M. Domínguez, P. Sancho-Bru, 2012, Gut.

Aphasia in a patient with acute hepatic encephalopathy associated with multifocal cortical brain lesions

J. García‐Pagán, N. Falgàs, I. Alfaro, 2018, Neurología (English Edition).

Aphasia in a patient with acute hepatic encephalopathy associated with multifocal cortical brain lesions.

J. García‐Pagán, J. Berenguer, J. C. García-Pagán, 2016, Neurologia.

Portal hypertension in acute liver failure.

J. Riera, M. Navasa, J. Rodés, 1992, Gut.

Liver sinusoidal endothelial dysfunction after LPS administration: a role for inducible-nitric oxide synthase.

J. Bosch, J. García‐Pagán, J. Abraldes, 2014, Journal of hepatology.

Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension

J. Bosch, J. García‐Pagán, S. Seijo, 2011, Gut.

Obeticholic acid: A new light in the shadows treating portal hypertension?

J. García‐Pagán, V. Hernández-Gea, J. Gracia‐Sancho, 2014, Hepatology.

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

J. Bosch, J. Calleja, J. García‐Pagán, 2016, Gastroenterology.

Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

A. de Gottardi, D. Semela, D. Valla, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Propranolol plus placebo versus propranolol plus isosorbide‐5‐mononitrate in the prevention of a first variceal bleed: A double‐blind RCT

J. Calleja, J. García‐Pagán, J. Genescà, 2003, Hepatology.

Isosorbide-5-monitrate (ISMN) vs placebo (PLA) in the prevention of the first variceal bleeding (FVB) in patients with contraindications or intolerance to beta-blockers

J. García‐Pagán, 2000 .

Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.

M. Mejías, E. García-Pras, J. García‐Pagán, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Time profile of the haemodynamic effects of terlipressin in portal hypertension.

J. Rodés, J. García‐Pagán, J. Bosch, 1997, Journal of hepatology.

Ascites after liver transplantation

The evolution of the TIPS placement technique and its applications over four decades.

J. García‐Pagán, Sarah Shalaby, Guangchuan Wang, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”

J. Trebicka, M. Merli, J. García‐Pagán, 2021, JHEP reports : innovation in hepatology.

Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

M. Rudler, D. Thabut, G. Han, 2023, Hepatology.

Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.

J. Rodés, J. García‐Pagán, J. Bosch, 1995, Gastroenterology.

Posters (Abstracts 289–2348)

D. Thabut, F. Nevens, M. Casas, 2019, Hepatology.

Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.

J. Rodés, J. Bosch, J. Bordas, 1997, Gastroenterology.

Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.

A. Nuzzo, J. García‐Pagán, M. Senzolo, 2024, The lancet. Gastroenterology & hepatology.

Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.

J. García‐Pagán, M. Alonso-Peña, M. Magaz, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.

C. Chagneau, D. Valla, H. Janssen, 2009, Journal of hepatology.

LIVER FAILURE AND LIVER DISEASE

S. Olliff, J. Bosch, E. Elias, 2004 .